The number of hospitalised patients was limited and in this pilot study we did not investigate the modulation of ACE2 and HMGB1 after glycyrrhizin administration in diseased patients, however, our data sustain the hypothesis of a potential use of glycyrrhizin in ARDS with and without viral infection. The gene discussed is HMGB1; the disease is acute respiratory distress syndrome.